GSDME has demonstrated inhibitory effects on cell proliferation and tumor progression in gastric cancer (GC), melanoma, colorectal cancer (CRC), and breast cancer, where its expression is upregulated, indicating its potential role as a tumor-suppressing agent (25, 34, 92). This evidence concerns the gene GSDME and melanoma.